Concept information
Preferred term
Tetrahydrocortisol
Type
-
mesh:Descriptor
Broader concept
Synonym(s)
- 53-02-1 (Tetrahydrocortisol)
- 7P2O6MFN8O
- Pregnan-20-one, 3,11,17,21-tetrahydroxy-, (3alpha,5beta,11beta)-
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
In other languages
-
French
-
53-02-1 (Tetrahydrocortisol)
-
7P2O6MFN8O
-
Composé F
-
Pregnan-20-one, 3,11,17,21-tetrahydroxy-, (3alpha,5beta,11beta)-
-
Tétrahydro F
-
THF (Tétrahydrocortisol F)
-
Urocortisol
URI
http://data.loterre.fr/ark:/67375/JVR-GVK0CCDC-N
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}